Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000229834 is annotated as a pseudogene, related to the NME4 (non-metastatic cells 4, nucleoside diphosphate kinase 4) protein-coding gene[3]. Pseudogenes are segments of DNA similar to known genes but typically non-functional due to mutations or deletions that prevent protein coding. There is no evidence that this pseudogene produces a functional protein, nor is it implicated as a therapeutic target. Research, therapeutic, or disease relevance for "non-metastatic cells 4, protein expressed in NME4" should instead refer to the actual NME4 gene or its protein product[3][1][4]. If you require information on the functional, druggable gene/protein, see "NME4" (NME/NM23 nucleoside diphosphate kinase 4), which is involved in nucleotide metabolism, mitochondrial function, and is associated with some cancers and metabolic diseases[1][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of non-metastatic cells 4, protein expressed in NME4.